Comparison of efficacy and safety of 1- and 3-month luteinizing hormone-releasing hormone agonist depots as initial therapies for prostate cancer

Author: Ishizuka Osamu  

Publisher: Springer Publishing Company

ISSN: 1341-9625

Source: International Journal of Clinical Oncology, Vol.18, Iss.3, 2013-06, pp. : 524-530

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content